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Edited by Peter BrzezinskiAbstract A rapid screening method for haemolytic activity,
using blood agar plates, has been developed to analyze randomly
produced mutant variants of the pore-forming protein sticholysin
II (Stn II). Those exhibiting a reduced activity were selected and
the DNA corresponding to each Stn II variant sequenced. Once
the mutation produced was determined, protein variants were
isolated and characterized in terms of structure (circular
dichroism spectra and thermal stability) and haemolytic activity.
Three single mutation protein variants, at residues K19, F106
and Y111, showed a signiﬁcantly decreased haemolytic activity
while their thermostability was identical to that of the wild-type
protein. Considering the obtained data and based on the three-
dimensional structure of the protein, the role of these residues on
the mechanism of haemolysis has been analyzed.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Actinoporins are a family of 20 kDa pore-forming proteins
produced by sea anemones displaying 65–85% sequence simi-
larity [1]. These cysteineless and basic proteins, highly soluble
in aqueous solvents, oligomerize to form cation-selective pores
in the presence of some phospholipid membranes [2,3], which
are responsible for their cytolytic eﬀect on erythrocytes,
platelets, and ﬁbroblasts [1]. The three-dimensional structures
of two actinoporins, equinatoxin II (Eqt II) from Actinia
equina and sticholysin II (Stn II) from Stichodactyla helianthus,
have been solved [4–6]. Both proteins display a very similar b-
sandwich fold composed of 10 b-strands ﬂanked on each side
by two short a-helices (Fig. 1A). The structure of a complex
between monomeric Stn II and phosphocholine (POC) has also
been determined [6], revealing the existence of a putative
phospholipid-binding site (Fig. 1B). In contrast to other pore-
forming proteins, the mechanism of actinoporin pore forma-
tion is poorly deﬁned in spite of the models derived from the* Corresponding author. Fax: +34-913944159.
E-mail address: alvaro@solea.quim.ucm.es (A. Martnez del Pozo).
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doi:10.1016/j.febslet.2004.08.031structural data [4–6]. Elucidation of speciﬁc protein residues
involved in the lytic action will improve the knowledge about
these proteins synthesized as water-soluble monomers but able
to form oligomeric pores within membranes. Based on this
idea, we have randomly produced mutants of Stn II in order to
select those with diminished haemolytic activity. We have de-
veloped a fast screening method useful to select those mutants
with an altered ability to lyse erythrocytes. The role of the
mutated residues has been discussed in terms of structure–
function relationships of this protein.2. Materials and methods
2.1. Production of the mutants
A 6His-tagged version of Stn II has been overproduced in Esche-
richia coli RB791 cells and puriﬁed to homogeneity [7]. The same
plasmid and strategy were used to produce and purify the mutants
selected. Recombinant DNA methods other than those reported below
were performed according to standard procedures [8]. Diversify PCR
Random Mutagenesis Kit (Clontech) was used to carry out controlled
random mutagenesis using the original plasmid as template where Stn
II was cloned (pQE306HStnII) [7]. Considering the Stn II-coding
cDNA size (550 bp) and following the manual instructions, a con-
centration of 0.2 mM Mg2þ was employed. In these conditions, the
mutation rate should be around 2 mutations per 1000 bp. This low
mutation rate was employed in order to minimize the introduction of
multiple changes within the same Stn II-coding cDNA molecule. The
ampliﬁed pool of DNA molecules was isolated, digested with BamHI
and HindIII, cloned again in pQE30 and used to transform E. coli
RB791 cells. In order to screen for their haemolytic activity, single
colonies were grown in 5 ml of LB at 37 C up to an OD600 of 1.0.
Then, IPTG was added to 2.0 mM ﬁnal concentration and the cells
were further incubated for 4 h. After this time, the cells were pelleted,
resuspended in 1.0 ml of water, and disrupted by ultrasonication. The
suspension was centrifuged at 14 000g for 10 min at 4 C. Superna-
tants were heated at 53 C for 10 min. Wild-type Stn II is a rather
thermostable protein [9] that remains fully haemolytic after this
treatment.
2.2. Haemolytic screening of the mutants
The haemolytic activity of the above solutions was analyzed in sheep
blood agar plates (Dismalab, Spain) by adding from 1:1 to 1:5 dilu-
tions of them, followed by an overnight incubation at 37 C. Omission
of the above heating step at 53 C resulted in growth of bacteria,
preventing the correct interpretation of the results. The haemolytic
fractions produced clear halos. This procedure is sensitive enough to
detect a haemolytic activity equivalent to that of 0.2 ng of Stn II. The
supernatants and resuspended pellets from colonies corresponding to
smaller or low-clarity halos were analyzed by means of 0.1% SDS–15%
PAGE, performed according to standard procedures [7], to identify
those that still produced enough of the recombinant protein. Thoseblished by Elsevier B.V. All rights reserved.
Fig. 1. (A) Diagram of the three-dimensional structure of Stn II (Protein Data Bank accession number 1GWY) where three of the residues mentioned
in the text are highlighted, Lys-19, Phe-106 and Tyr-111. (B) Diagram of the 3D-structure of Stn II where the aromatic residues involved in the POC-
binding site of the protein (in grey) are shown as well as Lys-19, Phe-106 and Tyr-111 (in black). Tyr-111 is part of the cluster of aromatic residues
involved in the POC-binding site [6]. Diagrams were generated with MOLMOL [15] and subsequently rendered with MegaPov.
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corresponding plasmid, using the GeneElute Miniprep Kit system
from Sigma. Finally, these DNA were sequenced at the DNA Se-
quencing Facility of the Complutense University in order to identify
the mutation presumably responsible for this lack of haemolytic
activity.
2.3. Proteins puriﬁcation
The E. coli colonies containing the mutants selected were grown in
one liter of LB-Amp and protein production was induced with IPTG,
as described above. The mutant proteins were puriﬁed as reported
before [7] for the wild-type protein. Essentially, the supernatant re-
sulting from the sonication of the cells was loaded onto a Ni2þ–ni-
trilotriacetic acid agarose (Ni–NTA) and eluted with 10 mM Mops
buﬀer, pH 8.0, containing 250 mM imidazole, after performing
washing steps with lower concentrations of imidazole [7]. Analysis of
total protein produced by the diﬀerent bacterial colonies assayed as
well as homogeneity of the puriﬁed proteins was performed by 0.1%
SDS–15% polyacrylamide gel electrophoresis.
2.4. Haemolytic assays
Haemolytic assays using sheep erythrocytes were performed as de-
scribed before [7,10]. Erythrocytes from heparinized sheep blood
(Dismalab, Spain) were washed and resuspended in 10 mM Tris–HCl,
pH 7.4, containing 0.145 M NaCl, to a ﬁnal concentration that resulted
in an OD540 of 0.7 when completely lysed by mixing 100 ll of the cell
suspension with 750 ll of 0.1% Na2CO3 (p/v). The standard haemo-
lytic assay was performed by adding increasing concentrations of
protein to 400 ll aliquots of the erythrocytes suspension, previously 4-
fold diluted with the same buﬀer. This reaction mixture was incubated
for 30 min at 37 C, with gentle shaking to avoid sedimentation of the
cells. Then, the tubes were microfuged and the absorbance values at
540 of the supernatants were measured in a spectrophotometer. The
percentage of haemolysis was calculated from the absorbance values
by comparison with that obtained after lysing the cells with 0.1%
Na2CO3 (p/v) as 100%. The HC50 (protein concentration required to
produce 50% haemolysis) was calculated from percentage of haemol-
ysis versus protein concentration plots.
2.5. Spectroscopic characterization
Protein solutions were prepared in 15 mM Mops buﬀer, pH 7.5,
containing 0.1 M NaCl at concentrations ranging from 0.2 to 1.0 mg/
ml depending on the spectroscopy used. Absorbance measurements
were carried out on an Uvikon 930 spectrophotometer at 100 nm/min
scanning speed, at room temperature, and in 1-cm optical-path cells.Far-UV circular dichroism (CD) spectra were obtained on a Jasco 715
spectropolarimeter at 0.2 nm/second scanning speed in 0.1-cm optical-
path cells. Each ﬁnal spectrum was the average accumulation of at
least four scans. Mean residue weight ellipticities were expressed in
units of degree cm2 dmol1. At neutral pH, Stn II is an associating
monomer–tetramer system with an association constant of 109 M3
[11], and its thermal denaturation occurs with a fast aggregation in a
concentration dependent process [9]. Thus, thermal denaturation
proﬁles of the protein can be obtained by measuring the temperature
dependence of either optical-path clariﬁcation (by CD measurements
at 218 nm) or Rayleigh light scattering (by ﬂuorescence measurements
at 330 nm for excitation at the same wavelength) [9] in the range of 25–
85 C, the temperature being continuously changed at a rate of 0.5 C/
min. Results are expressed as percentages of the total spectroscopic
variation versus temperature. The Tm value was considered as the
temperature at the midpoint of the monophasic thermal transitions
observed.3. Results and discussion
We have standardized an easy procedure for the screening of
haemolytic activity of Stn II in sheep blood agar plates that
produces reliable data (Fig. 2). Seventy-three diﬀerent E. coli
colonies transformed with a pool of randomly mutated
molecules of the pQE306HStnII plasmid were assayed for
haemolysis on these blood agar plates. Only 22 of them proved
non-haemolytic. Small-scale production experiments revealed
that 15 out of these 22 colonies produced signiﬁcant amounts
of a protein of the same molecular mass as wild-type Stn II,
according to their electrophoretic behaviour in SDS–PAGE.
Plasmids from these 15 colonies were isolated and the DNA
corresponding to each Stn II variant was completely se-
quenced. The mutations found are shown in Table 1.
Five of these colonies harboured mutated plasmids that re-
sulted in the production of an insoluble protein variant.
Therefore, these mutations impair the proper folding of the
proteins, which would explain their lack of solubility. Two of
them corresponded to the Trp-43 residue (W43R), two others
contained a double mutation (N65Y/F102L and F102L/
Fig. 2. Haemolytic assay on blood-agar plates. Diﬀerent amounts of
Stn II, dissolved in PBS, previously heated at 53 C for 10 min and
ranging from 4 lg to 0.25 ng were assayed. The clear halos correspond
to the haemolytic activity of the protein.
Table 1
Amino acid changes in Stn II deduced from the mutations detected in
the corresponding plasmids isolated from non-haemolytic colonies of
transformed E. coli RB791 cells that produced signiﬁcant amounts of
the protein
Mutationa
F14Y (+)
K19E (+)
N37S ())
W43Rb ())
N65Y/F102L ())
K67E (+)
F102L (+)
T97A/K118R (+)
N96D/Y135N (+)
F102L/G152E ())
G95E/W146G (+)
F106L (+)
Y111N (+)
N144S (+)
aAmino acid numeration is given according to the sequence of the
wild-type protein produced by the anemone Stichodactyla helianthus.
b This mutation was found twice; (+) the protein remains soluble after
ultrasonication or ()) appears in the insoluble pellet.
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residues (Asn65 was the only exception) are located in b-
strands. Trp-43 is buried in the hydrophobic core of the pro-
tein (Fig. 3A). Asn-37 is involved in two hydrogen bonds that
would maintain the loop between b2 and b3 strands (Fig. 3A).
Mutation of Phe-102 resulted in a dramatic decrease of the
protein stability (Table 2; see below), which when combined
with a second mutation would explain the insolubility of
N65Y/F102L and F102L/G152E. Three more mutants were
soluble but also contained a double mutation that would make
it diﬃcult to unambiguously assign the eﬀects observed.
The seven remaining mutant variants were produced and
puriﬁed to homogeneity. Their far-UV CD spectra (Fig. 4A)
were indistinguishable from that of the wild-type protein,
indicating that the active three-dimensional conformation of
Stn II was preserved. However, large diﬀerences were ob-
served in terms of their haemolytic activity against sheep
erythrocytes suspensions. As it can be observed in Table 2,
two groups of proteins could be distinguished. The ﬁrst one
displayed very similar HC50 values to the wild-type protein.
However, these variants showed a dramatically decreasedthermal stability (they showed a reduction in their Tm values
ranging between 12 and 20 C; Fig. 4B and Table 2), which
would explain the reduced haemolytic activity on agar-blood
plates of the producing colony. Therefore, these mutations
(F14Y, K67E, F102L, and N144S) correspond to amino acid
residues with a crucial role in the protein stability but not
involved in the haemolytic mechanism. In fact, when these
puriﬁed proteins were incubated for 10 min at a temperature
of 53 C, the corresponding HC50 values were 2–3-fold in-
creased (for F102L no haemolytic activity was observed even
at 20 nM protein concentration), while this treatment did not
modify the haemolytic activity of the wild-type protein.
Again, the localization of these mutations within the Stn II
structure is in accordance with this idea. All of them are
conserved in Eqt II and the ﬁrst three are also located in
elements of ordered secondary structure. Phe-14 is located in
the N-terminal a-helix and shows van der Waals interactions
(distance < 4.5 A) with Ile-160, Thr-162 and methylene
groups of Lys-168 (Fig. 3B). The one remaining, N144S,
corresponds to a residue of the loop connecting the second a-
helix and the b8 strand (Fig. 3B). It is close to Phe-14 and at
hydrogen bond distance of Ser-163. Lys-67, although highly
exposed, is a well ordered residue as deduced by the perfectly
deﬁned side chain electron density. This is probably due to
the existence of van der Waals interactions (distance < 4.0 A)
with Pro-64 and Ala-8, which presumably maintains Lys-67
in a conformation adequate for hydrogen bond formation
between the peptide NH group of Lys-67 and the CO group
of Pro-64 that may be of critical function in maintaining the
loop between b4 and b5 strands (Fig. 3C).
The other three mutant proteins remaining (K19E, F106L,
and Y111N) showed a signiﬁcantly decreased haemolytic ac-
tivity while their thermostability was identical to that of the
wild-type protein, at least in terms of their Tm values (Table 2).
Close inspection of Stn II three-dimensional structure allows
the discussion about the role of these residues on the mecha-
nism of haemolysis.
As indicated before, the main core of the Stn II three-
dimensional structure is a b-sandwich fold composed of 10 b-
strands, ﬂanked on each side by two short a-helices (Fig. 1A).
These a-helices interact with the b-sandwich predominantly
through hydrophobic interactions and van der Waals contacts,
but salt bridges are also observed [6]. The current model ac-
cepted to explain the pore formationmechanism of actinoporins
assumes that they must proceed through at least three steps:
monomeric binding to themembrane interface, assembly of four
monomers, and ﬁnal formation of the functional pore. Ac-
cording to this model, the N-terminal region would be involved
initially in oligomerization through interactions with the C-
terminal region of the adjacentmonomer [6]. Thus, the assembly
of four monomers at the membrane interface would involve
protein–protein interactions mediated by residues comprised
within the ﬁrst 29 amino acids stretch. Regarding the K19E
mutant, this lysine residue is located within the helix a1 pro-
truding out towards the solvent (Fig. 3D). Thus, it seems feasible
to consider that this residue might participate in establishing
interactions with the lipid interface and/or with an adjacent
monomer during the formation of the pore complex. In this
sense, according to the high resolution model of the tetrameric
assembly of Stn II, Lys-19 would be located in the close vicinity
of the lipid interface [6], which makes the ﬁrst possibility more
plausible. Moreover, this hypothesis would be consistent with
Fig. 3. Diagrams of detailed portions of the 3D-structure of Stn II (accession number 1GWY) corresponding to the environment of selected residues:
(A) Asn-37, Trp-43 and Asn-65; (B) Phe-14 and Asn-144; (C) Lys-67; (D) Lys-19; (E) Tyr-111 (this picture is obtained from the crystal structure of Stn
II-POC complex; Protein Data Bank accession number 1O72); (F) Phe-106. Diagrams were generated with MOLSCRIPT [16] and RASTER3D [17].
Fig. 4. (A) Far-UV circular dichroism spectrum of wild-type Stn II at
neutral pH. Vertical bars at selected wavelengths show the ellipticity
range where the spectra of the seven Stn II mutant variants puriﬁed are
included. Mean residue weight ellipticity values (h)MRW are expressed
in units of degree cm2 dmol1 of amino acid residue. (B) Thermal
denaturation proﬁles of: (s) wild-type Stn II; and mutant variants (m)
Y111N; (d) N144S; (D) K67E; (j) F102L; () F14Y; (r) K19E; ()
F106L. Values are expressed as percentages from CD measurements at
218 nm.
Table 2
Thermal stability and haemolytic activity parameters of wild-type Stn
II and its non-haemolytic soluble mutant variants
Protein Tm (C) DTm (C)a HC50 (nM) Relative HC50b
Wild-type 67 – 0.55 1.00
F14Y 55 )12 0.42 0.76
K19E 65 )2 3.86 7.02
K67E 55 )12 0.64 1.16
F102L 47 )20 0.46 0.84
F106L 66 )1 2.17 3.95
Y111N 67 0 1.37 2.49
N144S 55 )12 0.55 1.00
aDTm ¼ TmðmutantÞ  Tmðwild-typeÞ.
bRelative HC50¼HC50(mutant)/HC50(wild-type).
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residue near the lipid interface is energetically favourable [12]. If
such is the case, the charge reversal produced by the K19E
mutation would aﬀect dramatically to the stabilization eﬀect of
this interaction with the lipid interface, thus rendering this Stn II
variant as a less eﬃcient haemolytic protein.
In order to explain the eﬀect of the Y111N mutant it should
be taken into account that, according to the mentioned model,
the ﬁrst step of the pore forming mechanism would be binding
of Stn II monomers to the membrane interface. This stepwould be driven by binding of the POC moiety of some
phospholipids to a speciﬁc location of the protein [6]. This
location is a cavity where the positively charged choline is
stabilized by cation-p interactions with the aromatic rings of
Tyr-111 and Tyr-135 (Fig. 3E). Indeed, the phosphate moiety
18 J. Alegre-Cebollada et al. / FEBS Letters 575 (2004) 14–18of POC also interacts with the hydroxyl phenolic group of Tyr-
111. Obviously, neither of the two interactions can be estab-
lished for the Y111N variant of Stn II which can easily explain
why this mutant is less haemolytic than the wild-type protein.
This result also seems to conﬁrm the role previously assigned
to the Stn II POC binding site within the pore formation
mechanism.
The third less haemolytic mutation selected was F106L. This
Phe residue is located within the loop connecting strands b6
and b7 and quite close to the POC binding site in the three-
dimensional structure of Stn II (Fig. 1B). It is part of an ex-
posed cluster of aromatic amino acids which, at least in Eqt II,
participate in membrane binding [13]. Considering these ob-
servations, as well as the fact that these aromatic residues have
aﬃnity for the membrane interface [14], it is reasonable to
assume that a Leu residue could not play the role assigned to
this Phe in this regard. In fact, comparison of the structures of
free Stn II and that of the complex Stn II:POC revealed some
backbone modiﬁcations in the mentioned loop between
strands b6 and b7 [6], suggesting again that this protein region
is involved in binding to the membrane. Thus, the behaviour of
the F106L mutant would conﬁrm both the role of the POC-
binding site and the aromatic amino acids cluster in driving the
binding of Stn II to the membranes. In addition, Phe-106 in-
teracts with Arg-29 through cation-p interactions (Fig. 3F).
Arg-29 is located in the loop after the N-terminal a-helix,
which would act as a hinge region in the conformational
change involved in the 3D-model of the pore-like structures of
Stn II [6].
In summary, the method presented in this work to produce
and isolate diﬀerent mutant variants of Stn II has resulted to be
useful in selecting signiﬁcantly less haemolytic mutants which
maintain their overall native conformation and thermostability.
In addition, the analysis of the three protein variants containing
the single mutations K19E, F106L, and Y111N has also been
useful in order to discuss the role of speciﬁc regions of the
protein in terms of structure–function relationships.Acknowledgements: This research was supported by Grant BMC2003-
03227 (MCYT, Spain).References
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